We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
I'd be wary of this pinning everything on this Friday as some of us appear to be. The consultation ends on Friday, but the the NICE guidance is scheduled to be released in July.
Lionel , many thanks for the encouraging factual posts with links .. They have somewhat boasted my confidence further that GDR are about to make main stream.. TBH the strock test after hours of research sold the fact that this company can make millions , and the risk is small , if they dont get it together ...
lets hope they are working hard in the background and this kicks off ..
Just wondering , when we get the stroke test fully approved would it not make sense to swap the FDA applications round , it is more profitable , with NICE approval and another test to compare it too application would be so much easier and quicker????.
Tq BigH , Gino also said the same thing about pushing more tests with this POC device , i think Genedrive’s end goal is pushing this POC and tests through local GP’s and community pharmacist , coz this is easy to use and can digitally update the patient records ..
Some great posts and research Lionel, What we also have apart from the 2 tests is the IP on how these tests are developed , and as it seems to be ticking all the boxes this surely can be used to develop other tests , no brainer.
Video part : 2 , watch full video to find more about PGxand cost savings for NHS .
Bill Newman talks about GDR and POC use from 48th minute , very encouraged with his conclusion about the test.
https://youtu.be/u7dnJ46R3Ok?si=Zt90SacVkab4X0jr
Great video about PGX in NHS UK , GDR’s 2 test been discussed .. The speakers are confident that these will be routine tests soon .
https://youtu.be/fdp1lGdtnAY?si=fa_sQoh_O-_DFPGi
Similar statements from NHS Scotland .
https://www.gov.scot/publications/scotlands-genomic-medicine-strategy-2024-2029/pages/15/#
Its all about time saving and saving lives , hence in ref to the labs , expensive and time consuming ... POC is fast and effective ... The SP has now held ground for the last two weeks , giving many of us time to enter should be brave enough to take the risk with GDR , with their track record ... Its not often we these now , COVID was the time everyone and everyone siting at home jumped in anything that they thought was going to rocket .... now the Market is slow .. experienced investors left ... roll on friday
Personally think if NHS want more lab capacity they will just add it (that might take some time though). Having more lab capacity available also theoretically makes country more resilient to any future pandemic as well.
Finally roger is now being modest about decision make skills .. and has turned a corner again saying the sp will fly , this morning its was lights out ..
Well good luck all , we need it , friday if there is a Rns IS GOOD NEWS , IT WILL BE AFTER HOURS SO THEY CAN DO A RE RATE MONDAY MORNING ..
Stockpick - I think cheek is banking on draft Full recommendation being given at the end of this week. IF it lands and they even give out a rough estimate of how many tests might be used by the NHS in the near future (per year) then the sp will fly and a placing hopefully done on the back of such a rise. That's my only hope realistically not to be shafted twice by this stock and my own poor decisions.
Stock pick 3 .. what a name ... lol
GDR have a plan and a life saving device , needed in real time .. they have options .. and I am expecting a bumper of a RNS to set this on fire . launch right into the sky .. a long time coming .. its there time , as every dog has its day ... good luck all .. by the way , one think is a fact is that this will never see 3 p again .. what a stupid comment ..
Many thanks to Loinel for his informative posts , that are backed up with links and facts .. Unlike our friend Roger , hot air , no facts to support his de ramping ..
I was wondering if they would have to make RF another drawdown myself. Every day is closer to liquidation.
It would stave that off, of course, which is obviously better than the alternative. But we know what that always means for the share price. Millions more dumped at whatever price RF can get. Down down deeper and down as Status Quo used to sing.
I think you could argue that the fact RF haven’t got any more shares to unload at the moment explains the relative stability and quiescence of the share.
They have to do something though. They run out of cash in June right? And we are almost in May now. The fact that it has been left so late hardly strengthens the company hand in negotiations, does it?
Many thanks for the link Lionel!
A refreshing antedote to Rogers infected colon lol
The report suggests the test could be used for approx 35k cases but, as pointed out by Jimi, there isn't the capacity in the lab testing set up to cope with the increased demand. There is also a time factor so I'm thinking the CYP2C19 test may be used in the region of 35k - 50k times. That would still amount to about £3.5 - £4m worth of revenue (not profit). Anything like those figures will change the landscape here. Still worried about the pervasive negative comments from outside sources though within the report. Bit of a knife edge here now - hasn't that been said before of GDR?!
I really hope you,re both right...!!
Yes full recommendation coming, and crucially lab testing simply isn't going to be able to handle the number of tests required. There is nowhere near enough capacity for lab testing, so that's where the Genedrive test will shine. Additionally lab testing simply isn't fast enough in many instances, so again, the Genedrive test will be the best option.
It's getting a full recommendation for stroke product. But problem is that full recommendation for this is basically saying "only use when lab test not available". I think this stock is very unlikely to delist as not much for them to get from that as things stand right now.
3p incoming......not going to get FULL recommendation imho..then funding announced or taken Privaye imho....I hope I,m wrong completely though... after the last presentation they all looked fed up...so ..hence my optimism has drastically changed from positive to negative... GLA LTH,s
I'd be far more convinced if a major health fund/II bought in again or helped directly with fundraising as long-term investor. Even CEO/CFO buying would lend a little confidence to this. Guess they'll probably announce another drawdown from RF at the beginning of next month to keep the lights on.
This NHS Royal College of Physicians doc talks about both GDR POC tests and how this can be used during time critical settings … and also Read the forward looking statement from NHS chair .
https://www.rcplondon.ac.uk/file/36426/download
The public Consultation ends on Friday I think and it's possible a draft recommendation will be made but not officially published until July.
If it becomes clear it's not a FULL recommendation - and I take Muminr's points on board that NICE seem to be indicating it will be FULL - then it will be a bad weekend for share holders here. That might in fact precipitate GDR going private or being sold on the cheap. I think for now though Cheek doesn't want to go down that route. He appears to want to be rid of RF and get funding through other means and get the FDA partner announced asap. Someone's already said it, chicken and egg. IMO it's all hanging on this next bit of news from NICE. Hopefully it's good. If it is then sp should fly.
What’s happening Friday apart from it’s payday for most as the last Friday of the month?
Roger , I have given up on you :-) , good luck .
CYP2c19 kit is bigger than you think , it will get full recommendation, GDR has bigger plans than these 2 tests .. I will try to gather more data ..
https://www.nice.org.uk/news/article/nice-launches-second-consultation-on-genetic-testing-to-guide-treatment-after-a-stroke